AZD5153, a Bivalent BRD4 Inhibitor, Suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and Modulating the Transcriptome of HCC Cells

BRD4, a chromatin modifier frequently upregulated in a variety of neoplasms including hepatocellular cancer (HCC), promotes cancer cell growth by activating oncogenes through its interaction with acetylated histone tails of nucleosomes. Here, we determined the anti-HCC efficacy of AZD5153, a potent...

Full description

Bibliographic Details
Main Authors: Bai, X.-F (Author), Ghoshal, K. (Author), Koenig, A.B (Author), Kuo, J.C.-T (Author), Lee, R.J (Author), Li, D. (Author), Lin, C.-H (Author), Pan, A. (Author), Yan, P. (Author)
Format: Article
Language:English
Published: Frontiers Media S.A. 2022
Subjects:
HCC
Online Access:View Fulltext in Publisher